Article Information
History
- June 12, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Anna Lidia Wojdała1,
- Giovanni Bellomo1,
- Lorenzo Gaetani1,
- Dandan Shan2,
- Lucilla Parnetti1 and
- Davide Chiasserini3,*
- 1Laboratory of Clinical Neurochemistry, Section of Neurology, Department of Medicine and Surgery, University of Perugia, Perugia, 06132, Italy
- 2Quanterix Corporation, Billerica, Massachusetts, 01821, United States of America
- 3Section of Physiology and Biochemistry, Department of Medicine and Surgery, University of Perugia, Perugia, 06132, Italy
- ↵*Correspondence to: Davide Chiasserini, PhD, Section of Physiology and Biochemistry, Department of Medicine and Surgery, University of Perugia, Perugia, 06132, Italy; e-mail: davide.chiasserini{at}unipg.it; phone number: +39 075-5858197;.
Posted June 12, 2023.
Targeting multiphosphorylated tau: technical and clinical validation of a new Simoa® assay for CSF and plasma detection of tau simultaneously phosphorylated at T181 and T231
